Special Issue "Vaccine Vector"


A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (31 May 2014)

Special Issue Editor

Guest Editor
Dr. Michael Barry
Mayo Clinic, Rochester, MN 55902, USA
Website: http://www.mayo.edu/research/faculty/barry-michael-a-ph-d/BIO-00094964
E-Mail: Barry.Michael@mayo.edu
Interests: gene therapy for duchenne muscular dystrophy and propionic acidemia; gene-based vaccines for HIV and drug-resistant pathogens; anti-cancer virotherapy

Special Issue Information

Dear Colleagues,

This issue is directed towards the state of art in using gene-based vaccines against infectious diseases and in other applications. Particular focus will be on more recent developments of viral and non-viral vectors, alternate methods of vaccination, and the impact of systemic and mucosal immunization for effective vaccination.

Dr. Michael Barry
Guest Editor


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. For the first couple of issues the Article Processing Charge (APC) will be waived for well-prepared manuscripts. English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.


  • gene-based vaccines
  • viral vectors
  • non-viral vectors
  • gene gun
  • electroporation
  • replicating vectors
  • non-replicating vectors

Published Papers (3 papers)

Vaccines 2014, 2(3), 642-653; doi:10.3390/vaccines2030642
Received: 5 June 2014; in revised form: 24 July 2014 / Accepted: 25 July 2014 / Published: 5 August 2014
Show/Hide Abstract | PDF Full-text (408 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Vaccines 2014, 2(3), 624-641; doi:10.3390/vaccines2030624
Received: 22 April 2014; in revised form: 18 June 2014 / Accepted: 30 June 2014 / Published: 29 July 2014
Show/Hide Abstract | PDF Full-text (497 KB) | HTML Full-text | XML Full-text

by , , , , ,  and
Vaccines 2014, 2(3), 581-600; doi:10.3390/vaccines2030581
Received: 31 March 2014; in revised form: 9 June 2014 / Accepted: 25 June 2014 / Published: 22 July 2014
Show/Hide Abstract | PDF Full-text (1009 KB) | HTML Full-text | XML Full-text | Supplementary Files

Last update: 25 November 2013

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert